vs
Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Vericel Corp (VCEL). Click either name above to swap in a different company.
HEARTLAND EXPRESS INC is the larger business by last-quarter revenue ($179.4M vs $92.9M, roughly 1.9× Vericel Corp). Vericel Corp runs the higher net margin — 25.0% vs -10.8%, a 35.9% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -26.1%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-44.2M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -18.5%).
Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
HTLD vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $179.4M | $92.9M |
| Net Profit | $-19.4M | $23.2M |
| Gross Margin | — | 78.7% |
| Operating Margin | -12.7% | 24.1% |
| Net Margin | -10.8% | 25.0% |
| Revenue YoY | -26.1% | 23.3% |
| Net Profit YoY | -949.2% | 17.3% |
| EPS (diluted) | $-0.24 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $179.4M | $92.9M | ||
| Q3 25 | $196.5M | $67.5M | ||
| Q2 25 | $210.4M | $63.2M | ||
| Q1 25 | $219.4M | $52.6M | ||
| Q4 24 | $242.6M | $75.4M | ||
| Q3 24 | $259.9M | $57.9M | ||
| Q2 24 | $274.8M | $52.7M | ||
| Q1 24 | $270.3M | $51.3M |
| Q4 25 | $-19.4M | $23.2M | ||
| Q3 25 | $-8.3M | $5.1M | ||
| Q2 25 | $-10.9M | $-553.0K | ||
| Q1 25 | $-13.9M | $-11.2M | ||
| Q4 24 | $-1.9M | $19.8M | ||
| Q3 24 | $-9.3M | $-901.0K | ||
| Q2 24 | $-3.5M | $-4.7M | ||
| Q1 24 | $-15.1M | $-3.9M |
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
| Q4 25 | -12.7% | 24.1% | ||
| Q3 25 | -3.7% | 5.1% | ||
| Q2 25 | -5.9% | -3.2% | ||
| Q1 25 | -6.8% | -24.3% | ||
| Q4 24 | 0.4% | 24.5% | ||
| Q3 24 | -2.7% | -4.3% | ||
| Q2 24 | 0.1% | -11.5% | ||
| Q1 24 | -5.3% | -10.7% |
| Q4 25 | -10.8% | 25.0% | ||
| Q3 25 | -4.2% | 7.5% | ||
| Q2 25 | -5.2% | -0.9% | ||
| Q1 25 | -6.3% | -21.4% | ||
| Q4 24 | -0.8% | 26.3% | ||
| Q3 24 | -3.6% | -1.6% | ||
| Q2 24 | -1.3% | -8.9% | ||
| Q1 24 | -5.6% | -7.5% |
| Q4 25 | $-0.24 | $0.46 | ||
| Q3 25 | $-0.11 | $0.10 | ||
| Q2 25 | $-0.14 | $-0.01 | ||
| Q1 25 | $-0.18 | $-0.23 | ||
| Q4 24 | $-0.03 | $0.40 | ||
| Q3 24 | $-0.12 | $-0.02 | ||
| Q2 24 | $-0.04 | $-0.10 | ||
| Q1 24 | $-0.19 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.5M | $137.5M |
| Total DebtLower is stronger | $154.1M | — |
| Stockholders' EquityBook value | $755.3M | $354.6M |
| Total Assets | $1.2B | $488.0M |
| Debt / EquityLower = less leverage | 0.20× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.5M | $137.5M | ||
| Q3 25 | $32.7M | $135.4M | ||
| Q2 25 | $22.9M | $116.9M | ||
| Q1 25 | $23.9M | $112.9M | ||
| Q4 24 | $12.8M | $116.2M | ||
| Q3 24 | $30.7M | $101.7M | ||
| Q2 24 | $23.9M | $102.5M | ||
| Q1 24 | $23.8M | $110.6M |
| Q4 25 | $154.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $187.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $755.3M | $354.6M | ||
| Q3 25 | $775.6M | $321.9M | ||
| Q2 25 | $786.7M | $306.8M | ||
| Q1 25 | $807.7M | $295.5M | ||
| Q4 24 | $822.6M | $292.0M | ||
| Q3 24 | $825.7M | $257.5M | ||
| Q2 24 | $836.8M | $243.0M | ||
| Q1 24 | $848.8M | $233.9M |
| Q4 25 | $1.2B | $488.0M | ||
| Q3 25 | $1.3B | $453.3M | ||
| Q2 25 | $1.3B | $435.6M | ||
| Q1 25 | $1.3B | $424.6M | ||
| Q4 24 | $1.3B | $432.7M | ||
| Q3 24 | $1.4B | $390.4M | ||
| Q2 24 | $1.4B | $376.8M | ||
| Q1 24 | $1.5B | $356.7M |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.9M | $15.0M |
| Free Cash FlowOCF − Capex | $-44.2M | $12.8M |
| FCF MarginFCF / Revenue | -24.6% | 13.8% |
| Capex IntensityCapex / Revenue | 33.0% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-66.9M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.9M | $15.0M | ||
| Q3 25 | $27.5M | $22.1M | ||
| Q2 25 | $21.0M | $8.2M | ||
| Q1 25 | $25.8M | $6.6M | ||
| Q4 24 | $37.8M | $22.2M | ||
| Q3 24 | $35.6M | $10.2M | ||
| Q2 24 | $40.0M | $18.5M | ||
| Q1 24 | $31.0M | $7.2M |
| Q4 25 | $-44.2M | $12.8M | ||
| Q3 25 | $-12.2M | $19.5M | ||
| Q2 25 | $-12.8M | $81.0K | ||
| Q1 25 | $2.3M | $-7.6M | ||
| Q4 24 | $-45.5M | $8.5M | ||
| Q3 24 | $24.6M | $-9.2M | ||
| Q2 24 | $29.4M | $1.8M | ||
| Q1 24 | $26.3M | $-6.8M |
| Q4 25 | -24.6% | 13.8% | ||
| Q3 25 | -6.2% | 28.8% | ||
| Q2 25 | -6.1% | 0.1% | ||
| Q1 25 | 1.0% | -14.5% | ||
| Q4 24 | -18.8% | 11.2% | ||
| Q3 24 | 9.5% | -15.9% | ||
| Q2 24 | 10.7% | 3.4% | ||
| Q1 24 | 9.7% | -13.3% |
| Q4 25 | 33.0% | 2.4% | ||
| Q3 25 | 20.2% | 3.9% | ||
| Q2 25 | 16.1% | 12.9% | ||
| Q1 25 | 10.7% | 27.0% | ||
| Q4 24 | 34.3% | 18.3% | ||
| Q3 24 | 4.2% | 33.5% | ||
| Q2 24 | 3.8% | 31.8% | ||
| Q1 24 | 1.7% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTLD
Segment breakdown not available.
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
